Management of Kampavata (Parkinson’s Disease) through Panchakarma: A Successful Case Study

• Published in: Journal of pharmacology & pharmacotherapeutics Vol. 15; no. 3; pp. 362 - 368
• Main Authors: Mandal, Sonia, Sawarkar, Punam, Singh, Varinder, Parwe, Shweta, Sawarkar, Gaurav
• Format: Journal Article
• Language: English
• Published: New Delhi, India SAGE Publications 01.09.2024; Sage Publications Ltd
• Subjects: Patient satisfaction; Kampavata; Mahamasha oil; Zandopa powder; PD; Panchakarma
• ISSN: 0976-500X; 0976-5018
• DOI: 10.1177/0976500X241266049

Introduction Parkinson’s disease (PD) affects the central nervous system and is primarily characterized by the degeneration of dopamine-producing cells in the substantia nigra. Early signs include tremor, rigidity, bradykinesia, and postural instability, with later cognitive, sensory, sleep, and emotional issues. Ayurveda correlates these symptoms with Kampavata, primarily linked to Vata (bio-entities) imbalance. The prime aim of this paper is to study Panchakarma’s efficacy in managing Kampavata (PD). Case Presentation This is a case presentation of a 55-year-old male patient who has experienced tremors in the left upper and lower limbs, numbness in the left lower limb, loss of balance for 10 years, abnormal facial expression (masked face), difficulty in speech, and sleep disturbance for 5 years. The patient was treated with Panchakarma therapy for 30 days. Results Following treatment, the patient exhibited significant improvement in symptoms, assessed using the PD composite scale, with the total score decreasing from 68 to 19, along with evaluated by specific examination, bradykinesia test, reflexes, functional activities, and clinical features also notably improved. Discussion Panchakarma therapy, rooted in Ayurvedic principles, shows promise in managing Kampavata, associated with PD. Conservative management focuses on Vata balance, which offers substantial comfort and enhances patient quality of life. Conclusion Panchakarma therapy presents a potential avenue for treating Kampavata, addressing symptoms associated with PD, and improving patient satisfaction and well-being. Further research is warranted to validate these findings and explore the broader applicability of Ayurvedic approaches in neurodegenerative conditions.